Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCSW) Revenue (2021 - 2025)

Historic Revenue for HeartSciences (HSCSW) over the last 5 years, with Q4 2025 value amounting to $2419.0.

  • HeartSciences' Revenue rose 10205.7% to $2419.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$356010.0, marking a year-over-year decrease of 18384.52%. This contributed to the annual value of $4350.0 for FY2025, which is 7661.29% down from last year.
  • According to the latest figures from Q4 2025, HeartSciences' Revenue is $2419.0, which was up 10205.7% from $1900.0 recorded in Q3 2025.
  • In the past 5 years, HeartSciences' Revenue registered a high of $14700.0 during Q1 2024, and its lowest value of -$180852.0 during Q2 2025.
  • For the 5-year period, HeartSciences' Revenue averaged around -$35305.1, with its median value being $2184.5 (2023).
  • The largest annual percentage gain for HeartSciences' Revenue in the last 5 years was 65384.62% (2024), contrasted with its biggest fall of 311533.33% (2024).
  • HeartSciences' Revenue (Quarter) stood at $7484.0 in 2021, then tumbled by 57.24% to $3200.0 in 2022, then rose by 21.88% to $3900.0 in 2023, then crashed by 3115.33% to -$117598.0 in 2024, then soared by 102.06% to $2419.0 in 2025.
  • Its last three reported values are $2419.0 in Q4 2025, $1900.0 for Q3 2025, and -$180852.0 during Q2 2025.